Development of glycyrrhetinic acid ligand-functionalized liposomes for targeting hepatocellular carcinoma: synthesis, preparation, characterization, and evaluation

[1]  J. Chen,et al.  Glycyrrhetinic acid proliposomes mediated by mannosylated ligand: Preparation, physicochemical characterization, environmental stability and bioactivity evaluation. , 2022, Colloids and surfaces. B, Biointerfaces.

[2]  C. Zheng,et al.  Transarterial chemoembolization combined with camrelizumab for recurrent hepatocellular carcinoma , 2022, BMC Cancer.

[3]  S. Alexopoulos,et al.  Liver Transplantation for Pediatric Hepatocellular Carcinoma: A Systematic Review , 2022, Cancers.

[4]  M. Cristani,et al.  Recent Advances in Glycyrrhetinic Acid-Functionalized Biomaterials for Liver Cancer-Targeting Therapy , 2022, Molecules.

[5]  Jie Liu,et al.  Use of chemotherapy to treat hepatocellular carcinoma. , 2022, Bioscience trends.

[6]  Jing Chen,et al.  Drug-Free Liposomes Containing Mannosylated Ligand for Liver-Targeting: Synthetic Optimization, Liposomal Preparation, and Bioactivity Evaluation. , 2021, Journal of biomedical nanotechnology.

[7]  A. Rossi,et al.  Glycyrrhizic Acid and Its Hydrolyzed Metabolite 18β-Glycyrrhetinic Acid as Specific Ligands for Targeting Nanosystems in the Treatment of Liver Cancer , 2021, Pharmaceutics.

[8]  Ying-Hua Luo,et al.  18β-Glycyrrhetinic Acid Has Anti-Cancer Effects via Inducing Apoptosis and G2/M Cell Cycle Arrest, and Inhibiting Migration of A549 Lung Cancer Cells , 2021, OncoTargets and therapy.

[9]  Xiali Zhu,et al.  Glycyrrhetinic acid-decorated and docetaxel-loaded thermosensitive liposomes for combination therapy against hepatocellular carcinoma , 2021, Journal of Nanoparticle Research.

[10]  S. Terai,et al.  The promise of radiotherapy for hepatocellular carcinoma , 2021, Hepatology research : the official journal of the Japan Society of Hepatology.

[11]  Qingjie Sun,et al.  Fabrication and characterization of walnut peptides-loaded proliposomes with three lyoprotectants: Environmental stabilities and antioxidant/antibacterial activities. , 2021, Food chemistry.

[12]  Yan Wang,et al.  Hepatocellular Carcinoma Targeting and Pharmacodynamics of Paclitaxel Nanoliposomes Modified by Glycyrrhetinic Acid and Ferric Tetroxide. , 2021, Current topics in medicinal chemistry.

[13]  A. Cavaco‐Paulo,et al.  Design of liposomes as drug delivery system for therapeutic applications. , 2021, International journal of pharmaceutics.

[14]  A. Lechel,et al.  Iron at the Interface of Hepatocellular Carcinoma , 2021, International journal of molecular sciences.

[15]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[16]  Theodora A Seidu,et al.  Enhanced cellular uptake and cytotoxicity of vorinostat through encapsulation in TPGS-modified liposomes. , 2020, Colloids and surfaces. B, Biointerfaces.

[17]  Meihua Qu,et al.  Enhanced targeted delivery of adenine to hepatocellular carcinoma using glycyrrhetinic acid-functionalized nanoparticles in vivo and in vitro. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[18]  Satish Mishra,et al.  Functionally engineered 'hepato-liposomes': Combating liver-stage malaria in a single prophylactic dose. , 2020, International journal of pharmaceutics.

[19]  Yan Wang,et al.  Glycyrrhetinic acid and TAT peptide modified dual-functional liposomes for treatment of hepatocellular cancer. , 2020, Current topics in medicinal chemistry.

[20]  Yongjun Liu,et al.  A Review on Nano-Based Drug Delivery System for Cancer Chemoimmunotherapy , 2020, Nano-micro letters.

[21]  M. Battino,et al.  Effect of stabilizing agents on characteristics, antioxidant activities and stability of liposome loaded with hydrolyzed collagen from defatted Asian sea bass skin. , 2020, Food chemistry.

[22]  P. Park,et al.  Transcriptional suppression of androgen receptor by 18β-glycyrrhetinic acid in LNCaP human prostate cancer cells , 2020, Archives of pharmacal research.

[23]  Xiaoqing Zhang,et al.  18-GA-Suc Modified Liposome Loading Cantharidin for Augmenting Hepatic Specificity: Preparation, Characterization, Anti-Tumor Effects and Liver-Targeting Efficiency. , 2020, Journal of pharmaceutical sciences.

[24]  N. Terrault,et al.  Liver transplantation as therapy for hepatocellular carcinoma , 2020, Liver international : official journal of the International Association for the Study of the Liver.

[25]  J. Velázquez-Fernández,et al.  Nanomedicine review: clinical developments in liposomal applications , 2019 .

[26]  V. Mazzaferro,et al.  The chances of hepatic resection curing hepatocellular carcinoma. , 2019, Journal of hepatology.

[27]  T. Murakami,et al.  Significance of the surgical hepatic resection margin in patients with a single hepatocellular carcinoma , 2019, The British journal of surgery.

[28]  A. Malhotra,et al.  Potential of Ablation Therapy during Hepatocellular Carcinoma , 2019, Nutrition and cancer.

[29]  Yan-fang Yang,et al.  Drug-free mannosylated liposomes inhibit tumor growth by promoting the polarization of tumor-associated macrophages , 2019, International journal of nanomedicine.

[30]  T. Takayama,et al.  Liver resection for recurrent hepatocellular carcinoma after radiofrequency ablation therapy , 2019, Hepatology research : the official journal of the Japan Society of Hepatology.

[31]  M. Oliveira,et al.  Liquorice (Glycyrrhiza glabra): A phytochemical and pharmacological review , 2018, Phytotherapy research : PTR.

[32]  Wei Zhang,et al.  Preparation and characterization of norcantharidin liposomes modified with stearyl glycyrrhetinate , 2018, Experimental and therapeutic medicine.

[33]  Bixiang Zhang,et al.  18β-Glycyrrhetinic-acid-mediated unfolded protein response induces autophagy and apoptosis in hepatocellular carcinoma , 2018, Scientific Reports.

[34]  S. Kondo,et al.  Oral chemotherapy for the treatment of hepatocellular carcinoma , 2018, Expert opinion on pharmacotherapy.

[35]  Yudong Huang,et al.  Acid-sensitive polymeric vector targeting to hepatocarcinoma cells via glycyrrhetinic acid receptor-mediated endocytosis. , 2018, Materials science & engineering. C, Materials for biological applications.

[36]  Khaled Seidi,et al.  Tumor target amplification: Implications for nano drug delivery systems , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[37]  W. Ahmed,et al.  Proliposome tablets manufactured using a slurry-driven lipid-enriched powders: Development, characterization and stability evaluation. , 2018, International journal of pharmaceutics.

[38]  Z. Li,et al.  Modifying glycyrrhetinic acid liposomes with liver-targeting ligand of galactosylated derivative: preparation and evaluations , 2017, Oncotarget.

[39]  Youheng Gao,et al.  Glycyrrhetinic Acid Liposomes Containing Mannose-Diester Lauric Diacid-Cholesterol Conjugate Synthesized by Lipase-Catalytic Acylation for Liver-Specific Delivery , 2017, Molecules.

[40]  Haiyang Hu,et al.  Cellular uptake mechanism and clearance kinetics of fluorescence-labeled glycyrrhetinic acid and glycyrrhetinic acid-modified liposome in hepatocellular carcinoma cells. , 2017, Environmental toxicology and pharmacology.

[41]  Huali Chen,et al.  Glycyrrhetinic acid-functionalized mesoporous silica nanoparticles as hepatocellular carcinoma-targeted drug carrier , 2017, International journal of nanomedicine.

[42]  Wen-Chien Lu,et al.  Effects of storage conditions on the physical stability of d-limonene nanoemulsion , 2016 .

[43]  Meiwan Chen,et al.  Glycyrrhetinic Acid Mediated Drug Delivery Carriers for Hepatocellular Carcinoma Therapy. , 2016, Molecular pharmaceutics.

[44]  P. Das,et al.  18β‐glycyrrhetinic acid induces apoptosis through modulation of Akt/FOXO3a/Bim pathway in human breast cancer MCF‐7 cells , 2012, Journal of cellular physiology.

[45]  V. Minkin,et al.  Synthesis of glycyrrhetinic acid by hydrolysis of licorice root extract in subcritical water , 2010 .

[46]  Hatem Fessi,et al.  Ethanol injection method for hydrophilic and lipophilic drug-loaded liposome preparation , 2010, Journal of liposome research.

[47]  Marco M. Domingues,et al.  What can light scattering spectroscopy do for membrane‐active peptide studies? , 2008, Journal of peptide science : an official publication of the European Peptide Society.

[48]  A. Ichikawa,et al.  Specific binding of glycyrrhetinic acid to the rat liver membrane. , 1991, Biochimica et biophysica acta.

[49]  Jianbo Zhang,et al.  18β-glycyrrhetinic acid inhibits migration and invasion of human gastric cancer cells via the ROS/PKC-α/ERK pathway , 2017, Journal of Natural Medicines.